John G Ullman & Associates Inc Jazz Pharmaceuticals PLC Transaction History
John G Ullman & Associates Inc
- $631 Million
- Q4 2024
A detailed history of John G Ullman & Associates Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, John G Ullman & Associates Inc holds 39,750 shares of JAZZ stock, worth $5.52 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
39,750
Previous 45,094
11.85%
Holding current value
$5.52 Million
Previous $5.03 Million
2.61%
% of portfolio
0.78%
Previous 0.77%
Shares
4 transactions
Others Institutions Holding JAZZ
# of Institutions
544Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$854 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$839 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$352 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$308 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$283 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.71B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...